The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis

Figure 4

Kaplan-Meier analyses of overall survival in the subgroups of patients with LAHS (a) and benign disease-associated HLH (b) and serum β₂-m concentrations <4.03 mg/L and ≥4.03 mg/L at diagnosis ((a) ; (b) ).

(a)

(b)